Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence
Medicina Clínica · 2026
DOI: 10.1016/j.medcli.2026.107576 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Medicina Clínica, 2026. Verfasst von Larissa Milena de Moura Maia Senna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, State University of Bahia (UNEB), Salvador, Bahia, Brazil. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Lupus Erythematosus, Systemic, Immunosuppressive Agents. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Coordination for the improvement of Higher Education Personnel.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, State University of Bahia (UNEB), Salvador, Bahia, Brazil.
- Federal University of Bahia, Professor Edgar Santos University Hospital, SER Clinic of Bahia, Brazil.
- Department of Life Sciences, State University of Bahia (UNEB), Salvador, Bahia, Brazil. Electronic address: anibaljrr@uol.com.br.
Förderung
- Coordination for the improvement of Higher Education Personnel
Zitieren
APA
de Moura Maia Senna, L. M., Barreto Santiago, M., de Souza Lima, I. V., & de Freitas Santos Júnior, A. (2026). Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence. Medicina Clínica. https://doi.org/10.1016/j.medcli.2026.107576
Vancouver
de Moura Maia Senna LM, Barreto Santiago M, de Souza Lima IV, de Freitas Santos Júnior A. Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence. Medicina Clínica. 2026. doi:10.1016/j.medcli.2026.107576
BibTeX
@article{deMouraMaiaSenna2026,
author = {de Moura Maia Senna, Larissa Milena and Barreto Santiago, Mittermayer and de Souza Lima, Isabella Vargas and de Freitas Santos Júnior, Aníbal},
title = {Effectiveness of belimumab in reducing disease activity in patients with refractory systemic lupus erythematosus: Real-world evidence},
journal = {Medicina Clínica},
year = {2026},
doi = {10.1016/j.medcli.2026.107576}
}
EUVIMED